2019冠状病毒病前、大流行初期及疫苗接种后视神经炎与脑神经病变诊断率比较
这项多中心回顾性观察研究纳入5个学术中心323261例患者,比较2019冠状病毒病(COVID-19)大流行前、疫苗前及疫苗后三个时期神经眼科疾病的诊断率。结果显示,疫苗前时期面神经麻痹、复视、青光眼和白内障诊断率下降,但视神经炎诊断率上升,而视网膜脱离诊断率下降(P=0.021)。广泛接种疫苗后,所有眼科疾病诊断率均高于大流行前和疫苗前时期,且神经眼科诊断率升高未超过视网膜脱离和急性闭角型青光眼。
要点
- 疫苗前时期视神经炎诊断率上升,与视网膜脱离诊断率下降形成对比(P=0.021)。
- 疫苗后时期所有眼科疾病诊断率均高于大流行前和疫苗前时期。
- 各时期神经眼科诊断率对数比值比与急诊眼病(视网膜脱离和急性闭角型青光眼)大致相似(P>0.05)。
核心结论
- 大流行初期神经眼科疾病诊断率下降幅度与急诊眼病相似,但视神经炎例外。
- 广泛接种COVID-19疫苗后,所有眼科疾病诊断率均高于大流行前水平,神经眼科诊断率升高未超过视网膜脱离和急性闭角型青光眼。
研究设计与样本
- 多中心、回顾性、观察性研究,纳入5个学术中心323261例独特患者(中位年龄59岁,四分位距43-70,58%女性,68%白人)。
- 数据来源于多中心电子健康记录数据库Sight Outcomes Research Collaborative(SOURCE),查询2016年1月1日至2021年12月31日新诊断的神经眼科疾病和其他眼科疾病。
- 数据分为3个时期(COVID前、COVID疫苗前、COVID疫苗引入后),采用3年回顾期,使用逻辑回归比较各时期诊断率,并用两样本z检验比较各时期诊断对数比值比与急诊眼病(视网膜脱离和急性闭角型青光眼)。
主要发现
- COVID前时期就诊患者180009例,疫苗前时期149835例,疫苗时期164778例。
- 从COVID前时期到疫苗前时期,面神经麻痹、复视、青光眼和白内障诊断率下降。
- 疫苗前时期视神经炎诊断率上升,而视网膜脱离诊断率下降(P=0.021)。
- 疫苗时期所有评估的眼病诊断率均高于COVID前和疫苗前时期。
- 各时期神经眼科诊断率对数比值比与急诊眼病(视网膜脱离和急性闭角型青光眼)大致相似(P>0.05),但白内障和青光眼诊断对数比值比与视网膜脱离或急性闭角型青光眼不同(P<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare rates of diagnosis of neuro-ophthalmic conditions across the Coronavirus Disease 2019 (COVID-19) pandemic with pre-pandemic levels. DESIGN: Multicenter, retrospective, observational study. PARTICIPANTS: Patients seen for eye care between March 11, 2019, and December 31, 2021. METHODS: A multicenter electronic health record database, Sight Outcomes Research Collaborative (SOURCE), was queried for new diagnoses of neuro-ophthalmic conditions (cranial nerve [CN] III, IV, VI, and VII palsy; diplopia; and optic neuritis) and new diagnoses of other ophthalmic conditions from January 1, 2016, to December 31, 2021. Data were divided into 3 periods (pre-COVID, pre-COVID vaccine, and after introduction of COVID vaccine), with a 3-year look-back period. Logistic regressions were used to compare diagnosis rates across periods. Two-sample z-test was used to compare the log odds ratio (OR) of the diagnosis in each period with emergent ocular conditions: retinal detachment (RD) and acute angle-closure glaucoma (AACG). MAIN OUTCOME MEASURES: Diagnosis rate of neuro-ophthalmic conditions in each study period. RESULTS: A total of 323 261 unique patients (median age 59 years [interquartile range, 43-70], 58% female, 68% White) across 5 academic centers were included, with 180 009 patients seen in the pre-COVID period, 149 835 patients seen in the pre-COVID vaccine period, and 164 778 patients seen in the COVID vaccine period. Diagnosis rates of CN VII palsy, diplopia, glaucoma, and cataract decreased from the pre-COVID period to the pre-vaccine period. However, the optic neuritis diagnoses increased, in contrast to a decrease in RD diagnoses (P = 0.021). By comparing the diagnosis rates before and after widespread vaccination, all eye conditions evaluated were diagnosed at higher rates in the COVID vaccination period compared with pre-COVID and pre-vaccine periods. The log OR of neuro-ophthalmic diagnosis rates across every period comparison were largely similar to emergency conditions (RD and AACG, P > 0.05). However, the log OR of cataract and glaucoma diagnoses were different to RD or AACG (P < 0.05) in each period comparison. CONCLUSIONS: Neuro-ophthalmic diagnoses had a similar reduction in diagnosis rates as emergent eye conditions in the first part of the pandemic, except optic neuritis. After widespread COVID-19 vaccination, all ophthalmic diagnosis rates increased compared with pre-pandemic rates, and the increase in neuro-ophthalmic diagnosis rates did not exceed the increase in RD and AACG diagnosis rates. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
引用
- Zhao D, Li X, Carey AR, et al. Optic Neuritis and Cranial Neuropathies Diagnosis Rates before Coronavirus Disease 2019, in the Initial Pandemic Phase, and Post-Vaccine Introduction. Ophthalmology. 2023. PMID: 37634758. doi:10.1016/j.ophtha.2023.08.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。